Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells

Autor: Michela Massollo, Silvia Morbelli, Cecilia Marini, Antonio Uccelli, Sabrina Chiesa, Elisabetta Traggiai, Sara Morando, Soraya Tabera Bartolomé, Arinna Bertoni, Gianmario Sambuceti, Francesco Frassoni
Rok vydání: 2011
Předmět:
CD4-Positive T-Lymphocytes
Stromal cell
T-Lymphocytes
Cellular differentiation
T cell
Antigen presentation
Gene Expression
Priming (immunology)
Mice
Transgenic

CD8-Positive T-Lymphocytes
Biology
Inbred C57BL
Animals
Antigen Presentation
CD4-Positive T-Lymphocytes

immunology
CD8-Positive T-Lymphocytes

immunology
Cell Differentiation

immunology
Cell Movement

immunology
Coculture Techniques
Cytokines

genetics
Dendritic Cells

cytology/immunology/physiology/transplantation
Gene Expression
Lymph Nodes

cytology/immunology
Mesenchymal Stem Cells

immunology
Mice
Mice

Inbred BALB C
Mice

Inbred C57BL
Mice

Transgenic
Signal Transduction

immunology
T-Lymphocytes

immunology
Toll-Like Receptor 4

genetics/immunology
Transgenic
immunology
Mice
Cell Movement
cytology/immunology
medicine
Animals
genetics
cytology/immunology/physiology/transplantation
Progenitor cell
Inbred BALB C
Mice
Inbred BALB C

Antigen Presentation
Multidisciplinary
Mesenchymal stem cell
Cell Differentiation
Mesenchymal Stem Cells
Dendritic Cells
Biological Sciences
Molecular biology
Coculture Techniques
Cell biology
Mice
Inbred C57BL

Toll-Like Receptor 4
medicine.anatomical_structure
Cytokines
Lymph Nodes
CD8
Signal Transduction
Zdroj: Proceedings of the National Academy of Sciences. 108:17384-17389
ISSN: 1091-6490
0027-8424
Popis: Dendritic cells (DC) are highly specialized antigen-presenting cells characterized by the ability to prime T-cell responses. Mesenchymal stem cells (MSC) are adult stromal progenitor cells displaying immunomodulatory activities including inhibition of DC maturation in vitro. However, the specific impact of MSC on DC functions, upon in vivo administration, has never been elucidated. Here we show that murine MSC impair Toll-like receptor-4 induced activation of DC resulting in the inhibition of cytokines secretion, down-regulation of molecules involved in the migration to the lymph nodes, antigen presentation to CD4 + T cells, and cross-presentation to CD8 + T cells. These effects are associated with the inhibition of phosphorylation of intracellular mitogen-activated protein kinases. Intravenous administration of MSC decreased the number of CCR7 and CD49dβ1 expressing CFSE-labeled DC in the draining lymph nodes and hindered local antigen priming of DO11.10 ovalbumin-specific CD4 + T cells. Upon labeling of DC with technetium-99m hexamethylpropylene amine oxime to follow their in vivo biodistribution, we demonstrated that intravenous injection of MSC blocks, almost instantaneously, the migration of subcutaneously administered ovalbumin-pulsed DC to the draining lymph nodes. These findings indicate that MSC significantly affect DC ability to prime T cells in vivo because of their inability to home to the draining lymph nodes and further confirm MSC potentiality as therapy for immune-mediated diseases.
Databáze: OpenAIRE